1. Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: Invasion and Inflammation. Microbiol Spectr. 2019 Mar;7(2): 10.1128/microbiolspec.GPP3-0004-2018. [
DOI:10.1128/9781683670131.ch20]
2. Luck JN, Tettelin H, Orihuela CJ. Sugar-Coated Killer: Serotype 3 Pneumococcal Disease. Front Cell Infect Microbiol. 2020 Dec 23; 10:613287. [
DOI:10.3389/fcimb.2020.613287]
3. Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH. Pneumococcal Capsules and Their Types: Past, Present, and Future. Clin Microbiol Rev. 2015 Jul;28(3):871-99. [
DOI:10.1128/CMR.00024-15]
4. Ataee RA, Habibian S, Mehrabi-Tavana A, Ahmadi Z, Jonaidi N, Salesi M. Determination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniae in Iran. Annals of clinical microbiology and antimicrobials. 2014; 13:53. [
DOI:10.1186/s12941-014-0053-1]
5. Ataee RA, Hossaini SMJ, Karami A, Safiri Z, Allahverdi M. Simultaneous detection of common bacterial meningitis: Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumonia by multiplex PCR. Trauma Monthly. 2009;14(3):119-26.
6. Ataee RA, Mehrabi Tavana A, Karami A, Izadi M, Hasani SMJ, Safiri Z, et al. The assessment of universal primer for rapid detection of bacterial meningitis. Hakim Res J. 2009;11(4):27-32.
7. Hamaguchi S, Zafar MA, Cammer M, Weiser JN. Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation. Infect Immun. 2018 Feb 20;86(3): e00802-17. [
DOI:10.1128/IAI.00802-17]
8. Paton JC, Trappetti C. Streptococcus pneumoniae Capsular Polysaccharide. Microbiol Spectr. 2019 Mar;7(2). [
DOI:10.1128/microbiolspec.GPP3-0019-2018]
9. Denapaite D, Hakenbeck R. A New Variant of the Capsule 3 Cluster Occurs in Streptococcus pneumoniae from Deceased Wild Chimpanzees. PLoS ONE. 2011;6(9):25119. [
DOI:10.1371/journal.pone.0025119]
10. Habibian S, Mehrabi-T A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J, et al. Serotype Distribution and Antibiotics Susceptibility Pattern of Streptococcus pneumonia in Iran. Iran. Red Crescent Med J. 2013;15(10):8053. [
DOI:10.5812/ircmj.8053]
11. Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, et al. Bergey's Manual of Systematic Bacteriology. 2nd ed. New York: 2009.704.
12. Hyams C, Trzcinski K, Camberlein E, M.Weinberger D,Chimalapati S,Noursadeghi M, et al. Streptococcus pneumoniae Capsular Serotype Invasiveness Correlates with the Degree of Factor H Binding and Opsonization with C3b/iC3b. Infect Immun. 2012;81(1):354. [
DOI:10.1128/IAI.00862-12]
13. Obaro S, Adegbola R. The Pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 2002;51(2):98-104. [
DOI:10.1099/0022-1317-51-2-98]
14. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among Pneumococcal serotypes. Lancet Infect Dis. 2005;5(2):39-83. [
DOI:10.1016/S1473-3099(05)70083-9]
15. Standish AJ, Salim AA, Zhang H, Capon RJ, Morona R. Chemical Inhibition of Bacterial Protein Tyrosine Phosphatase Suppresses Capsule Production. PLoS ONE. 2012;7(5):1-3. [
DOI:10.1371/journal.pone.0036312]
16. Mäkinen KK, Bennett CA, Hujoel PP, Isokangas PJ, Isotupa KP, Pape HR Jr Et al. Xylitol chewing gums and caries rates. a 40-month cohort study. J Dent Res (74). (74):1904-13. [
DOI:10.1177/00220345950740121501]
17. Kontiokari T, Uhari M, Koskela M. Effect of xylitol on growth of nasopharyngeal bacteria in vitro. Antimicrob Agents Chemother. 1995 (39):1820-3. [
DOI:10.1128/AAC.39.8.1820]
18. Kontiokari T, Uhari M, Koskela M. Antiadhesive effects of xylitol on otopathogenic bacteria. J Antimicrob Chemother. 1998 (41):563-5. [
DOI:10.1093/jac/41.5.563]
19. Tapiainen T, Kontiokari T, Sammalkivi L, Ikäheimo I, Koskela M, Uhari M. Effect of xylitol on growth of Streptococcus pneumoniae in the presence of fructose and sorbitol. Antimicrob Agents Chemother. 2001 (45):166-9. [
DOI:10.1128/AAC.45.1.166-169.2001]
20. Kurola P, Tapiainen T, Kaijalainen T, Uhari M, Saukkor iipi A. Xylitol and capsular gene expression in Streptococcus pneumoniae. Journal of Medical Microbiology. 2009; 58:1470-3. [
DOI:10.1099/jmm.0.011700-0]
21. Russell H, Tharpe JA, Wells DE, White EH, Johnson JE. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae. J Clin Microbiol. 1990; 28:2192-5. [
DOI:10.1128/jcm.28.10.2191-2195.1990]
22. Sampson JS, Furlow Z, Whitney AM, Williams D, Facklam R, Carlone GM. Limited diversity of Streptococcus pneumoniae psaA among pneumococcal vaccine serotypes. Infect Immun. 1997;65(5): 1967-71. [
DOI:10.1128/iai.65.5.1967-1971.1997]
23. Berry A, Paton JC. Sequence heterogeneity of PasA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect Immun. 1996; 64:5255-62. [
DOI:10.1128/iai.64.12.5255-5262.1996]
24. Morrison KE, Lake D, Crook J, Carlone GM, Ades E, Facklam R, et al. Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol. 2000;38(1): 434-7. [
DOI:10.1128/JCM.38.1.434-437.2000]
25. Ataee RA, Mehrabi-Tavana A, and Esmaili D. Serotyping Distribution of Invasive Pneumococcal Disease (IPD) in Iranian patients. J Pure Appl Microbiol. 2012; 6(1): 155-160.
26. Habibian S, Mehrabi-Tavana A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J, et al. Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. Iran Red Crescent Med J. 2013;15(10):e8053. [
DOI:10.5812/ircmj.8053]
27. Tavana AM, Ataee R, Gerami M, Gooya M, Karami A, Ranjbar R, et al. A study investigating the Streptococcus Pneumoniae pattern among Iranian patients. Archives of Pharmacy Practice. 2012;3(2):122. [
DOI:10.4103/2045-080X.112808]
28. Mohsenpoor M, MehrabiTavana A, Ataee R A, Ranjbar R, Mirnejad R. Isolation and Identification of Streptococcus pneumoniae from Admitted Patients in Tehran Hospitals in during 2013-2015. Iran J Med Microbiol. 2017; 11(2):09-16.
29. Asgari A, Ataee RA, Ghorbanalizadegan M, MehrabiTavana A . Diagnosis of Streptococcus pneumoniae based on cpsB , cpsD and psaA Genes. J Mazandaran Univ Med Sci. 2018;28(161)121-126.
30. Kanık Yüksek S, Gülhan B, Tezer H, Özkaya Parlakay A,Uzun Kenan B, Sayed Oskovi H,et al. Invasive pneumococcal disease in two non-vaccinated pediatric cases: pleural empyema and bacteremia. Mikrobiyol Bul. 2015;49(3):446-53. [
DOI:10.5578/mb.9742]
31. Hanage WP, Fraser C, Tang J, Connor TR, Corander J. Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus. Science. 2009; 324;1454-7. [
DOI:10.1126/science.1171908]
32. Asgari A, Ataee RA, Ghorbanalizadegan M, MehrabiTavana A. Effect of Xylitol on the Growth and Survival of Streptococcus pneumoniae. Jundishapur J Microbiol. 2018;11(12)e69319.